Genmab | Beneficio Operativo

Name: Genmab | Beneficio Operativo
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

width

height

	Operating Profit		Fecha
Agios Pharmaceuticals AGIO:US	$ -89.22M	2M	2021-06
Alexion Pharmaceuticals ALXN:US	$ 636.2M	14.1M	2021-03
Amarin AMRN:US	$ -1.33M	8.49M	2021-03
Amgen AMGN:US	$ 828M	1301M	2021-06
AstraZeneca AZN:LN	1.13B	768M	2021-06
Bayer BAYN:GR	3.08B	1.57B	2021-03
Biomarin Pharmaceutical BMRN:US	$ 11.67M	13.41M	2021-06
Bluebird Bio BLUE:US	$ -231.21M	27.23M	2021-03
Exelixis EXEL:US	$ -4.61M	28.9M	2021-03
Fresenius Medical Care FME:GR	€ 424M	50M	2021-06
Galapagos GLPG:NA	-50798000	35.32M	2021-03
Genmab GEN:DC	532M	355M	2021-03
GlaxoSmithKline GSK:LN	1.68B	18M	2021-06
GN Store Nord GN:DC	712M	20M	2021-03
GRIFOLS GRF:SM	€ 250.6M	37.64M	2021-06
H. Lundbeck A/S LUN:DC	882M	678M	2021-03
Hikma Pharmaceutical HIK:LN	309M	16M	2020-12
Immunogen IMGN:US	$ -27.37M	1.55M	2021-06
Insmed INSM:US	$ -83833000	10.7M	2021-03
Lonza Group LONN:SW	317M	34M	2021-06
Novartis NOVN:VX	3.48B	1.06B	2021-06
Regeneron Pharmaceuticals REGN:US	$ 1112.7M	54.3M	2021-03
Seattle Genetics SGEN:US	$ -89.6M	32.82M	2021-06
William Demant Holding WDH:DC	1.42B	1.3B	2020-12

Genmab Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2021.